Syndrome

Microbiota modification and reabsorption of eubiosis may help reduce COVID-19 complications

Getting the elderly vaccine first for COVID-19 saves most lives

Researchers are studying differences in reactions to SARS-CoV-2 infection between children and adults

New research suggests innovative antibody-based treatment to prevent viral infiltration of SARS-CoV-2

Living with a COVID-19 case results in worse symptoms and a stronger antibody response

Colombia’s new SARS-CoV-2 line shares antibody-resistant mutations with other modifications

Combination therapy can reduce the morbidity and mortality associated with influenza

New study tests how mutations in SARS-CoV-2 affect antibody neutralization

Examination of post-acute sequelae of SARS-CoV-2 infection shows 8-month persistent symptoms

The new SARS-CoV-2 line has spread across many Brazilian states